Why does cholecystokinin increase in critically ill patients?
Asai
Takashi
T
D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000502:physiology*; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness / Q000628:therapy*; D004750:Enteral Nutrition / Q000009:adverse effects / Q000379:methods*; D005746:Gastric Emptying / Q000187:drug effects / Q000502:physiology; D006801:Humans
D002766:Cholecystokinin